You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T-cell Lymphoproliferative Disorder

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

Recruiting
  • Epstein-Barr Virus Infections
  • +2 more
  • Group A
  • Group B
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Apr 5, 2022

LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

Recruiting
  • LGLL - Large Granular Lymphocytic Leukemia
  • +13 more
  • Duarte, California
  • +9 more
Aug 9, 2022

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Recruiting
  • Benign Lymphoproliferative Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Immunosuppression Only Conditioning
    • +3 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

    Not yet recruiting
    • T-Cell Neoplasm
    • Lymphoproliferative Disorders
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Oct 6, 2022

    Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disorder
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jan 16, 2023

    Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder Trial

    Not yet recruiting
    • Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder
    • Polymorphic Post-Transplant Lymphoproliferative Disorder
    • Biopsy
    • +5 more
    • New Brunswick, New Jersey
    • +2 more
    Mar 23, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Hematopoietic and Lymphoid Cell Tumor, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston

    Active, not recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +13 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 8, 2022

    Lymphoma Trial in Stanford (rituximab)

    Completed
    • Lymphoma
    • rituximab
    • Stanford, California
      Stanford University Medical Center
    May 25, 2022

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Busulfan test dose
    • +8 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T

    Recruiting
    • Hodgkin's Disease
    • +3 more
    • EBV-specific T cells: A
    • EBV-specific T cells: B
    • Houston, Texas
    • +1 more
    Jun 28, 2022

    Accuracy Evaluation of the IdentiClone Dx IGH Assay

    Not yet recruiting
    • B-Cell Lymphoproliferative Disorder
    • IdentiClone Dx IGH (IC IGH Dx) Assay
    • San Diego, California
    • +2 more
    Oct 30, 2023

    Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

    Recruiting
    • Hodgkin Disease
    • +5 more
    • MABEL CTLs
    • +2 more
    • Houston, Texas
    • +1 more
    Jan 13, 2023

    Post-Transplant Lymphoproliferative Disorder, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Seattle

    Not yet recruiting
    • Post-Transplant Lymphoproliferative Disorder
    • +10 more
    • Loncastuximab Tesirine
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2022

    EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

    Not yet recruiting
    • EBV Lymphoma
    • Post-transplant Lymphoproliferative Disease (PTLD)
    • Donor-derived ex-vivo expanded EBV Tscm CTL
    • Basel, Switzerland
    • +7 more
    Jan 25, 2023

    Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

    Recruiting
    • Primary T-cell Immunodeficiency Disorders
    • +4 more
    • Immunosuppression Only Conditioning -Closed with amendment L
    • +4 more
    • Bethesda, Maryland
    • +1 more
    Jul 26, 2022

    Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

    Not yet recruiting
    • Allogeneic Stem Cell Transplant Candidate
    • +4 more
    • Cellular therapy product
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 1, 2022

    Epstein-Barr Virus Associated Lymphoproliferative Disorder, EBV-Related PTLD, EBV Related Non-Hodgkin's Lymphoma Trial in

    Recruiting
    • Epstein-Barr Virus Associated Lymphoproliferative Disorder
    • +7 more
    • Nanatinostat in combination with valganciclovir
    • Birmingham, Alabama
    • +57 more
    Aug 10, 2022

    Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • iCaspase9-transduced T cells
    • AP1903
    • Houston, Texas
    • +1 more
    Jul 22, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

    Terminated
    Has Results
    • Adult Grade III Lymphomatoid Granulomatosis
    • +116 more
    • brentuximab vedotin
    • +2 more
    • Chicago, Illinois
    • +2 more
    Aug 30, 2021

    Hematopoietic Organs; Disorder Trial in Hong Kong (CD62L depleted donor lymphocyte infusion)

    Recruiting
    • Hematopoietic Organs; Disorder
    • CD62L depleted donor lymphocyte infusion
    • Hong Kong, Hong Kong
      Hong Kong Children's Hospital
    Sep 6, 2023